Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression.

Serebruany, V L; Ordonez, J V; Herzog, W R; Rohde, M; Mortensen, S A; Folkers, K; Gurbel, P A

Serebruany, V L; Ordonez, J V; Herzog, W R; Rohde, M; Mortensen, S A; Folkers, K; Gurbel, P A.

Affiliation

Serebruany VL; Heart Associates Research & Education Foundation, Baltimore, Maryland 21218, USA.

J Cardiovasc Pharmacol ; 29(1): 16-22, 1997 Jan.

Article in En | MEDLINE | ID: mdl-9007665

Subject(s)

Blood Platelets/drug effects; Food, Fortified; Receptors, Vitronectin/antagonists & inhibitors; Ubiquinone/analogs & derivatives; Adult; Antibodies, Monoclonal; Antigens, CD/analysis; Blood Platelets/metabolism; Coenzymes; Female; Flow Cytometry; Humans; Integrin alphaV; Integrin beta3; Male; Particle Size; Platelet Membrane Glycoproteins/analysis; Receptors, Vitronectin/biosynthesis; Receptors, Vitronectin/immunology; Ubiquinone/administration & dosage; Ubiquinone/blood; Ubiquinone/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Blood Platelets / Food, Fortified / Ubiquinone / Receptors, Vitronectin Type of study: Guideline Language: En Journal: J Cardiovasc Pharmacol Year: 1997 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links